Literature DB >> 22521832

Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.

M Baarine1, P Andréoletti, A Athias, T Nury, A Zarrouk, K Ragot, A Vejux, J-M Riedinger, Z Kattan, G Bessede, D Trompier, S Savary, M Cherkaoui-Malki, G Lizard.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) and pseudo neonatal adrenoleukodystrophy (P-NALD) are neurodegenerative demyelinating diseases resulting from the functional loss of the peroxisomal ATP-binding cassette transporter D (ABCD1) and from single peroxisomal enzyme deficiency (Acyl-CoA oxidase1: ACOX1), respectively. As these proteins are involved in the catabolism of very long chain fatty acids (VLCFA: C24:0, C26:0), X-ALD and P-NALD patients are characterized by the accumulation of VLCFA in plasma and tissues. Since peroxisomes are involved in the metabolism of reactive oxygen species (ROS) and nitrogen species (RNS), we examined the impact of VLCFA on the oxidative status of 158N murine oligodendrocytes expressing or not Abcd1 or Acox1. VLCFA triggers an oxidative stress characterized by an overproduction of ROS and RNS associated with lipid peroxidation, protein carbonylation, increased superoxide dismutase (SOD) activity, decreased catalase activity and glutathione level. SiRNA knockdown of Abcd1 or Acox1 increased ROS and RNS production even in the absence of VLCFA, and especially potentialized VLCFA-induced ROS overproduction. Moreover, mainly in cells with reduced Acox1 level, the levels of VLCFA and neutral lipids were strongly enhanced both in untreated and VLCFA - treated cells. Our data obtained on 158N murine oligodendrocytes highlight that VLCFA induce an oxidative stress, and demonstrate that Abcd1 or Acox1 knockdown contributes to disrupt RedOx equilibrium supporting a link between oxidative stress and the deficiency of Abcd1 or Acox1 peroxisomal proteins.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521832     DOI: 10.1016/j.neuroscience.2012.03.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  30 in total

1.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.

Authors:  Gani Oruqaj; Srikanth Karnati; Vijith Vijayan; Lakshmi Kanth Kotarkonda; Eistine Boateng; Wenming Zhang; Clemens Ruppert; Andreas Günther; Wei Shi; Eveline Baumgart-Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 3.  Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases.

Authors:  Rachayeeta Deb; Neha Joshi; Shirisha Nagotu
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

4.  Linoleic and α-linolenic fatty acid consumption over three generations exert cumulative regulation of hepatic expression of genes related to lipid metabolism.

Authors:  Carolina B Jacometo; Eduardo Schmitt; Luiz F M Pfeifer; Augusto Schneider; Francielle Bado; Fernanda T da Rosa; Simone Halfen; Francisco A B Del Pino; Juan J Loor; Marcio N Corrêa; Nelson J L Dionello
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

5.  Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency.

Authors:  Ivana Geric; Yulia Y Tyurina; Olga Krysko; Dmitri V Krysko; Evelyn De Schryver; Valerian E Kagan; Paul P Van Veldhoven; Myriam Baes; Simon Verheijden
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

6.  Structure-function analysis of peroxisomal ATP-binding cassette transporters using chimeric dimers.

Authors:  Flore Geillon; Catherine Gondcaille; Soëli Charbonnier; Carlo W Van Roermund; Tatiana E Lopez; Alexandre M M Dias; Jean-Paul Pais de Barros; Christine Arnould; Ronald J Wanders; Doriane Trompier; Stéphane Savary
Journal:  J Biol Chem       Date:  2014-07-20       Impact factor: 5.157

7.  Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.

Authors:  Yi Gong; Dakai Mu; Shilpa Prabhakar; Ann Moser; Patricia Musolino; JiaQian Ren; Xandra O Breakefield; Casey A Maguire; Florian S Eichler
Journal:  Mol Ther       Date:  2015-01-16       Impact factor: 11.454

8.  Peripheral nervous system defects in a mouse model for peroxisomal biogenesis disorders.

Authors:  M Gartz Hanson; Veronica L Fregoso; Justin D Vrana; Chandra L Tucker; Lee A Niswander
Journal:  Dev Biol       Date:  2014-08-28       Impact factor: 3.582

Review 9.  Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain.

Authors:  Peter Schönfeld; Georg Reiser
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

10.  Detection and Quantification of Free Radicals in Peroxisomal Disorders: A Comparative Study with Oxidative Stress Parameters.

Authors:  Sohair Abd-El Mawgood Abd-Elmaksoud; Hala El-Bassyouni; Hanan Afifi; Manal Micheal Thomas; Alshaymaa Ahmed Ibrahim; Aliaa Shalaby; Tamer Ahmed Abdel Hamid; Nehal Abdel Hamid; Hany El-Ghobary
Journal:  J Clin Diagn Res       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.